Pilot Study of Zoledronic Acid and Interleukin-2 for Refractory Pediatric Neuroblastoma

NCT01404702 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped Accrual slower than anticipated

Conditions

Neuroblastoma

Interventions

DRUG: Zoledronic Acid
BIOLOGICAL: Aldesleukin

Sponsor

University of Alabama at Birmingham